Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Watson Restructuring To Create Brand, Generic Units

Executive Summary

Watson believes it may take up to six months to complete its search for two presidents to head up the company's new brand and generic business units

You may also be interested in...

Ex-Watson COO joins Cardinal

Cardinal Health names former Watson COO Joseph Papa as CEO-pharmaceutical technologies and services business. Papa will be responsible for drug development, formulation, sterile manufacturing, packaging and marketing services. Papa chose not to remain at Watson as president-brand business under the company's reorganization (1"The Pink Sheet" Nov. 1, 2004, p. 22)...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts